RECURSION PHARMACEUTICALS IN

Ticker: RXRX CUSIP: 75629V104 Class: Common Stock

Erste Asset Management GmbH's Holding History (CIK: 0002024532)

Note: Option positions (PUT/CALL) are excluded.

Q2 2025
Shares 33,500 Value ($000) $169 Avg Close $4.91 Range $3.79 - $6.11
Q1 2025
Shares 33,500 Value ($000) $195 Avg Close $7.29 Range $5.19 - $12.36
Q4 2024
Shares 33,500 Value ($000) $248 Avg Close $6.72 Range $5.60 - $9.55
Q3 2024
Shares 33,500 Value ($000) $234 Avg Close $7.17 Range $5.88 - $8.73
Q2 2024
Shares 33,500 Value ($000) $254 Avg Close $8.72 Range $6.75 - $10.66
Q1 2024
Shares 33,500 Value ($000) $341 Avg Close $11.14 Range $8.68 - $15.74
Q4 2023
Shares 33,500 Value ($000) $355 Avg Close $7.13 Range $4.97 - $11.17
Q3 2023
Shares 33,500 Value ($000) $260 Avg Close $9.98 Range $6.44 - $16.75
Q2 2023
Shares 33,500 Value ($000) $247 Avg Close $7.00 Range $4.54 - $10.45
Q1 2023
Shares 33,500 Value ($000) $216 Avg Close $7.93 Range $6.40 - $9.73
Q4 2022
Shares 33,500 Value ($000) $257 Avg Close $9.81 Range $7.04 - $13.29
Q3 2022
Shares 33,500 Value ($000) $360 Avg Close $10.13 Range $7.48 - $14.18
Q2 2022
Shares 33,500 Value ($000) $270 Avg Close $6.69 Range $4.92 - $9.40
Q1 2022
Shares 33,500 Value ($000) $239 Avg Close $10.63 Range $5.80 - $18.23